Skip to main content

Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · IEX Real-Time Price · USD
9.64
-0.21 (-2.13%)
At close: Nov 26, 2021 1:00 PM
9.30
-0.34 (-3.53%)
After-hours:Nov 26, 2021 4:42 PM EST
Market Cap252.23M
Revenue (ttm)170,000
Net Income (ttm)-16.16M
Shares Out26.16M
EPS (ttm)-0.63
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume96,546
Open9.89
Previous Close9.85
Day's Range9.28 - 9.94
52-Week Range5.80 - 10.08
Beta-0.07
AnalystsStrong Buy
Price Target14.00 (+45.2%)
Earnings DateNov 15, 2021

About FENC

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Trian...

IndustryBiotechnology
IPO DateJun 5, 2001
CEORostislav Raykov
Employees9
Stock ExchangeNASDAQ
Ticker SymbolFENC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for FENC stock is "Strong Buy." The 12-month stock price forecast is 14.00, which is an increase of 45.23% from the latest price.

Price Target
$14.00
(45.23% upside)
Analyst Consensus: Strong Buy

News

Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update

~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~

2 weeks ago - GlobeNewsWire

4 Breakout Stocks for Impressive Returns

SB, VTSI, FENC and APYX qualified the screen for breakout stocks for today.

Other symbols:APYXSBVTSI
1 month ago - Zacks Investment Research

Here's Why "Trend" Investors Would Love Betting on Adherex Technologies Inc. (FENC)

Adherex Technologies Inc. (FENC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

1 month ago - Zacks Investment Research

Here's Why Momentum in Adherex Technologies Inc. (FENC) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, Adherex Technologies Inc. (FENC) could be a great choice. It is one of the several stocks that passed through our...

2 months ago - Zacks Investment Research

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique ...

2 months ago - GlobeNewsWire

Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update

~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~

3 months ago - GlobeNewsWire

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circu...

4 months ago - GlobeNewsWire

Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility

RESEARCH TRIANGLE PARK, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique ...

5 months ago - GlobeNewsWire

Fennec Pharma Stock Is Trading Higher As Pedmark Is Under FDA Review For Chemo-Induced Toxicity

The FDA has accepted for review Fennec Pharmaceuticals Inc's (NASDAQ: FENC) resubmitted marketing application seeking approval for Pedmark (formulated sodium thiosulfate) to prevent ototoxicity induced ...

5 months ago - Benzinga

Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK™

~ Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~

5 months ago - GlobeNewsWire

Fennec Pharma Refiles Pedmark US Application For Cisplatin-Induced Ototoxicity In Pediatric Patients

Fennec Pharmaceuticals Inc (NASDAQ: FENC) has resubmitted its marketing application to the FDA seeking approval for Pedmark (formulated sodium thiosulfate) for the prevention of ototoxicity (toxic to th...

5 months ago - Benzinga

Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for PEDMARK™

~ If Approved by the FDA, PEDMARK Stands to Be the First Therapy for the Prevention of Cisplatin-Induced Hearing Loss in Children ~ ~ If Approved by the FDA, PEDMARK Stands to Be the First Therapy for t...

5 months ago - GlobeNewsWire

Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update

~ Fennec Remains on Track to Finalize and Resubmit the New Drug Application for PEDMARK™ to the U.S. Food and Drug Administration in the Second Quarter of 2021 ~

6 months ago - GlobeNewsWire

Fennec Announces Fiscal Year 2020 Financial Results and Provides Business Update

~ Fennec is Working Closely with its Third-Party Drug Product Manufacturer to Finalize the New Drug Application (NDA) Resubmission for PEDMARK™ ~

7 months ago - GlobeNewsWire

Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update

~ The Company Continues to Work with the FDA and Its Third-Party Drug Product Manufacturer to Fully Address CRL and Prepare NDA Resubmission for PEDMARK™  ~

1 year ago - GlobeNewsWire

FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 2, 2020 in the Class Action Filed on B...

New York, New York--(Newsfile Corp. - November 2, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fennec Pharmaceuticals Inc. (NASDAQ: FENC...

1 year ago - Newsfile Corp

FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important ...

NEW YORK, Nov. 2, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. between February 11, 2020 and August 10, 202...

1 year ago - PRNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsu...

New York, New York--(Newsfile Corp. - November 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of F...

1 year ago - Newsfile Corp

FENC Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and L...

New York, New York--(Newsfile Corp. - November 2, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. ("Fennec" o...

1 year ago - Newsfile Corp

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc...

Los Angeles, California--(Newsfile Corp. - November 2, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec Pharmace...

1 year ago - Newsfile Corp

FENC Final Deadline Alert: Rosen, Top Ranked Global Counsel, Reminds Fennec Pharmaceuticals Inc. Investors of the Imp...

New York, New York--(Newsfile Corp. - October 30, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between Fe...

1 year ago - Newsfile Corp

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pha...

LOS ANGELES--(BUSINESS WIRE)---- $FENC #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action file...

1 year ago - Business Wire

FENC Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action...

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC)...

1 year ago - Business Wire

DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceutic...

Los Angeles, California--(Newsfile Corp. - October 30, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fennec Pharmaceu...

1 year ago - Newsfile Corp

FENC CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files a Securities Fraud Class Action Lawsuit Against Fenn...

LOS ANGELES, Oct. 29, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Middle District of North Caroli...

1 year ago - PRNewsWire